What do you really care about?
We know most nurses went into the profession to provide proper care and attention. To make a difference.6 However, these days, it is not that simple. There are more patients 7, increased cost constraints 8,9,10, and fewer colleagues to pitch in. 11 Pressures are growing at either end of the spectrum. There are older patients with more complications,12 and younger patients with higher expectations. 7
The result? Healthcare professionals feel they have too little time to provide the kind of care patients deserve.
When it feels like everything is stacked against you, you need simplicity and performance from the foamdressings you use, and the company that provides them.
With ALLEVYN Wound Dressings, we’re shaping what’s possible in wound care.
More of what you care about, straight to your inbox?
+ Releasing time
It’s possible to release valuable time
ALLEVYN Wound Dressings are designed to give back valuable time.1-3,14,15,16 Time to plan. Time to talk.Time to care. Whether it’s the extended wear time of dressings 1,216-19, ease of application,repositioning and removal 4,14,16,20-27 or enabling shared wound care practices,1,2,28 ALLEVYN WoundDressings work hard to give you back time. We know you value your time. We can help you to releaseit.
- Extended wear time 1,216-19
- Ease of application, repositioning and removal 4,14,16, 20-27
- Shared wound care 1,2,28
Download related publication summaries on:
ALLEVYN LifeorALLEVYN GB
+ Wasting less
It’s possible to produce less waste
Daily wound care practice involves routinely using supplies, creating substantial waste. Focusing onreducing carbon emissions and the respectful use of global resources, we have spearheaded packagingoptimisation for our product ranges.
With their extended wear time‡, 1,2,16-19 and reduced dressing failures**14,26,30-32 ALLEVYN WoundDressings are also helping to reduce the burden of waste, with up to 20% less packaging 29 *† , positivelyimpacting the associated costs.
For practices and clinicians, using ALLEVYN Wound Dressings means:
- Less dressing failures** 14,26,30-32
- Less dressings used 14,26,30-32†
- Less packaging used 29,33 *
- Less waste and more care
+ Improving lives
It’s possible to improve the lives of your patients
Living with a chronic wound can result in patients living in pain, with mental health issues, and insocial isolation.34,35 Regular and often unnecessary dressing changes can also be hugely disruptive to lives, such asimpacting job security.36
Over three decades of clinical use, we’ve listened to clinicians and their patients. To support them, we continueto innovate our ALLEVYN Foam Dressings with essential quality-of-life features, such as high conformability,4,14,16,22,37-40 and comfort,4,14,16,22,30 extended wear time,1,2,16-19 advanced lock-in and absorptiontechnologies2,4,22,34,35, and easy application, repositioning and removal.4,14,16, 20-27 Together, we can make a realdifference to wound patients’ lives.
As you know, patients are concerned with the aspects of living with a wound that disrupt daily life:2
- Comfort and pain upon removal
- Odour
- Ease of use
- Unsightly exudate strikethrough
- Leakage
- Dressing change frequency
- Independence
Download related publication summaries on:
ALLEVYN Life or ALLEVYN GB
ALLEVYN Wound Dressings are absorbent,40-42 protective40-43 and gentle.14,44
ALLEVYN Wound Dressings provide you with the essentials you expect from a foam dressing, and more.
A range of five-layer and three-layer dressings, designed to support a range of wound management and prevention requirements and are available in a wide range of shapes and sizes.
Absorbent 40-42
The ALLEVYN hydrocellular foam core innovatively balances absorption and retention to create a moist woundhealing environment 4,14,32,44,45, with minimised risk of maceration. 14,32,44
Protective 40-43
The ALLEVYN breathable, waterproof 45-48 top film provides a bacterial barrier,49 while the dressing remainsintact.
Gentle 14,44
The ALLEVYN gentle wound contact adhesives are easy to apply, reposition and remove 4,14,16, 20-27 and areshown to minimise pain and trauma during dressing changes. 14,32
ALLEVYN Life Foam Dressings
Provide trusted performance, helping save time and money.2,28
With unique body-conforming design, wide borders, and flexible layers ALLEVYN LIFE Dressings will allow youto help patients get on with their lives4,30,34
1. EXUMASK◊ CHANGE INDICATOR
Minimises the visual impact of absorbed exudate and works as an indicator as to when to change, which helpsminimise unnecessary changes.2,30
2. EXULOCK◊ HYPER-ABSORBENT LOCK-AWAY LAYER
Absorbs and locks in exudate2,4,50 and helps control wound malodour2,4,51
3. UNIQUE SHAPES AND WIDE BORDERS
The unique quadrilobe heel and sacral shapes fit the contours of the human body securely.1,4,30
ALLEVYN Gentle Border Foam Dressings
Trusted to conform and stay in place 14,21,52-54
With a variety of shape and sizes to suit multiple wound types, ALLEVYN GENTLE BORDER Dressings willallow you to help a wide range of patients’ wounds 37-39,53
1. MULTI-SITE UNIQUE TRILOBE DRESSING
Conforms closely to difficult to dress body areas, whilst allowing flexibility of the joint 14,37-39
2. MULTI-WAY STRETCH TECHNOLOGY
Helps with application on awkward areas, and helps maximise patient comfort 14,37-39
Meet the full range
Caring beyond products
Our commitment to comprehensive wound care goes beyond providing products. It includes initiatives such as the COMPASS Programme helping to achieve better wound care outcomes, the formeo Digital Wound Management Ecosystem for simplified ordering and the COMPASS Clinical Support App that aids wound assessment and decision-making.
We prioritize continuous learning through medical education delivered both on-site and online via platforms like Wound Club Online and programs like T3.
Citations
* As demonstrated in laboratory testing
**Instances of unanticipated dressing failures arise from poor performance, such as dressing leakage due to lifting borders, weak adherence to the skin and excessive visible dressingstrikethrough
- Joy H, Bielby A, Searle R. A collaborative project to enhance efficiency through dressing change practice. J Wound Care 2015;24(7):312, 314 – 3172. Tiscar-González V, Menor-Rodríguez MJ, Rabadán-Sainz C, et al. Clinical and Economic Impact of Wound Care Using a Polyurethane Foam Multilayer Dressing. Adv Skin Wound Care. 2021;34(1):23-30.3. Forni C, Searle R. A multilayer polyurethane foam dressing for pressure ulcer prevention in older hip fracture patients: an economic evaluation. J Wound Care. 2020;29(2):120-1274. Rossington A, Drysdale K, Winter R. Clinical performance and positive impact on patient wellbeing of ALLEVYN Life. Wounds UK. 2013;9(4):91 – 955. Smith+Nephew 14 June 2012.Odour reducing properties of ALLEVYN Life. Internal Report. DS/12/127/DOF.6. McKenna L, et al; Nurses’ and nursing students’ reasons for entering the profession: content analysis of open-ended questions BMC Nurs. 2023; 22: 152 Published online 2023 May 5. doi: 10.1186/s12912-023-01307-8)7. Guest et al, Cohort study evaluating the burden of wounds to the UK's National Health Service in 2017/2018: update from 2012/2013 BMJ Open. 2020 Dec 22;10(12):e045253. doi: 10.1136/bmjopen-2020-0452538. Milne J, Searle R, Styche T. The characteristics and impact of hard-to-heal wounds: results of a standardised survey. J Wound Care. 2020;29(5):282–2889. Lindholm C, Searle R. Wound management for the 21st century: combining effectiveness and efficiency. Int Wound J. 2016;13 Suppl 2:5–15)10. Wassel C, Delhougne G, Gayle J et al. Risk of readmissions, mortality, and hospital-acquired conditions across hospital-acquired pressure injury (HAPI) stages in a US National Hospital discharge database. Int Wound J. 2020; 1–11.11. INTERNATIONAL COUNCIL OF NURSES POLICY BRIEF: online link… ICN Policy Brief_Nurse Shortage and Retention.pdf 12. Viamontes L, Jones, A.M, Evaluation study of the properties of two adhesive foam dressings. British Journal of Nursing (Tissue Viability Supplement). 2003;12(11):S43-S49).13. S+N Data on file. The Nursery (Research Agency). Community nursing research summary. Self-care approaches to patient wound care and the impact of Covid-19. 2021.14. Hurd T, Gregory L, Jones A, Brown S.A multi-centre in-market evaluation of ALLEVYN Gentle Border. Wounds UK. 2009;5(3):32-44.15. Vowden K, Harding K, Moiemen N, Drysdale K, Mistry C. An open, prospective randomised, multi-centre clinical evaluation of a hydrocellular silicone foam dressing* in the management of exuding chronic and acute wounds. Paper presented at: EWMA; 2011; Brussels16. Kurring PA, Roberts CD, Quinlan D. Evaluation of a hydrocellular dressing in the management of exuding wounds in the community British Journal of Nursing 1994;3(20):1049-1050, 1052-1043 ss and efficiency. Int Wound J. 2016;13 Suppl 2:5–15)17. Smith & Nephew 2017. An open, prospective, randomised, comparative volunteer trial to compare the performance of silicone adhesive dressings. Internal Report. GMCA-DOF-10.18. Smith & Nephew 2017. An open, prospective, randomised, comparative study to compare the performance of ALLEVYN Gentle Border Multisite with an alternative silicone adhesive dressing. Internal Report. GMCA-DOF-09.19. Smith & Nephew 2017. ALLEVYN Gentle Border wound model - 10 x 10. Internal Report. DS/17/491/R.20. Grothier L. Gentle foam dressings: interim results of an evaluation of the Allevyn range. British journal of nursing 2009;18(11):S12, S14, S16 passim21. Callaghan R, Chadwick P, Mahoney K, Stephen-Haynes J.Case series evaluation: The use of Allevyn gentle border multisite on chronic wounds. Wounds UK. 2012;8(4):110-11822. Foster AVM, Greenhill MT, Edmonds ME. Comparing two dressings in the treatment of diabetic foot ulcers. Journal of Wound Care. 1994;3(5):224 – 228.23. Smith & Nephew 2008. ALLEVYN Gentle Border dressings assessment in terms of retention on thighs - HVT046. Internal Report. GMCA-DOF/04.24. Clarke R. Positive patient outcomes: The use of a new silicone adhesive foam dressing for pressure ulcer prevention and treatment. Paper presented at: CAET; 2013.25. Lisco C. Evaluation of a new silicone gel-adhesive hydrocellular foam dressing as part of a pressure ulcer prevention plan for ICU patients. Paper presented at: WOCN; 2013.26. Stephen-Haynes, J et al AMG. Clinical evaluation of Allevyn Gentle Border Lite within one health trust. British Journal of Nursing. 2011;20(20):36-42.27. Smith+Nephew 2015.ALLEVYN Gentle Border dressings assessment in terms of retention on thighs. Internal Report. GMCA-DOF/04.28. Moore Z, Forni C, Mcguiness W. Raising the Standards of care for reducing PU incidence and maintaining skin integrity. Paper presented at: EPUAP Symposium; 2017; Belfast, Northern Ireland.29. Smith+Nephew 2022. Methodology for the reduction in packaging material of ALLEVYN◊ Bordered Dressings. Internal report CSD.AWM.22.045.30. Simon D, Bielby A. A structured collaborative approach to appraise the clinical performance of a new product. Wounds UK. 2014;10(3): 80-87.31. Smith+Nephew 2022.Post Market Clinical Followup (PMCF) Report for ALLEVYN GENTLE. CSD.AWM. 22.050.32. Leonard S, Mccluskey P, Long S, et al An evaluation of ALLEVYN Adhesive and Non-Adhesive Foam dressings. Wounds UK. 2009. 5(1): 17-28).33. Smith+Nephew 2023. Methodology for calculating the reduction in global packaging material of ALLEVYN◊ Non bordered dressings. Internal report CSD.AWM.23.0014.34. Fearns, N., Heller-Murphy, S., Kelly, J., Harbour, J. Placing the patient at the centre of chronic wound care: A qualitative evidence synthesis. Journal of Tissue Viability, Vol 26, Issue 4, Nov 2017 pp 254-259. https://doi.org/10.1016/j.jtv.2017.09.00235. Klein TM, Andrees V, Kirsten N, Protz K, Augustin M, Blome C. Social participation of people with chronic wounds: A systematic review. Int Wound J. 2021 Jun;18(3):287-311. doi:10.1111/iwj13533. Epub 2020 Dec 13. Available from:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244007/ (Accessed: 01Mar23)36. Sen, C.K. Human Wound and Its Burden: Updated 2020 Compendium of Estimates. Advances in Wound Care. 202137. Smith & Nephew 2016. ALLEVYN Gentle Border Heel Gen 2 – physical evaluation. Internal Report. DS/16/465/R.38. Smith & Nephew 2017. ALLEVYN Gentle Border Gen 2 -Physical Evaluation. Internal Report. DS/16/424/R V3.39. Rafter L, Reynolds T, Rafter M.An audit of patient outcomes in the management of skin tears using silicone dressings. Wounds UK.2016;12(2):70-78.40. DS/16/424/R Version 3 - AGB physical evaluation41. ALLEVYN Adhesive dressing physical properties. DS/09/013/R7.42. DOF 0702001. - Ag Non adhesive physical properties.43. Forni C, Gazineo D, Allegrini E, et al. Effectiveness of a multi-layer silicone-adhesive polyurethane foam dressing as prevention for sacral pressure ulcers in at-risk in-patients: Randomized controlled trial. International Journal of Nursing Studies. 2022;127:104172.44. Smith+Nephew 2022.Post Market Clinical Follow-up (PMCF) Report for ALLEVYN GENTLE. CSD.AWM. 22.050.45. White, R., Hartwell, S., and Brown, S., Interim report on a study to assess the effectiveness and improved fluiduptake of new ALLEVYN. Wounds UK. 2007; 3(4):122-12746. DS/16/424/R Version 3 - AGB physical evaluation47. ALLEVYN Adhesive dressing physical properties. DS/09/013/R7.48. DOF 0702001. - Ag Non adhesive physical properties.49. Smith+Nephew 2023. Bacterial barrier properties of the ALLEVYNTM Dressing Range. Internal Report. CSD.AWM.23.032.50. S+N Data on File. Wound Model Testing of New ALLEVYN Life Gen2 IM:I Dressing using Horse Serum at a Row Rate Modelling that of a Moderately Exuding Wound. DS/14/303/R. 2016.51. S+N Data on File. Odour reducing properties of ALLEVYN LIFE. Internal Report. DS/12/127 /DOF. 2012.52. Davies A, Harish S, Price J. Selecting dressings to manage exudate and enhance patient wellbeing. Wounds UK. 2015;11(3):54-6153. Hampton S. An evaluation of a silicone adhesive shaped heel dressing. Br J Nurs. 2010;19(6):S30-33.54. Stephen-Haynes J, Greenwood M, Merrick J, Callaghan R. Dressing challenging anatomical areas: the Allevyn Gentle Border range. 2012;17:S38-S44.